Cargando…

IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid

Bullous Pemphigoid (BP) is a skin autoimmune blistering disease characterized by immune-mediated degradation of the dermo-epidermal junction and release of a large number of inflammatory cytokines. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory cytokine associated with inflammasome activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Jan, Sébastien, Muller, Céline, Plee, Julie, Durlach, Anne, Bernard, Philippe, Antonicelli, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718471/
https://www.ncbi.nlm.nih.gov/pubmed/31507596
http://dx.doi.org/10.3389/fimmu.2019.01972
_version_ 1783447731928301568
author Le Jan, Sébastien
Muller, Céline
Plee, Julie
Durlach, Anne
Bernard, Philippe
Antonicelli, Frank
author_facet Le Jan, Sébastien
Muller, Céline
Plee, Julie
Durlach, Anne
Bernard, Philippe
Antonicelli, Frank
author_sort Le Jan, Sébastien
collection PubMed
description Bullous Pemphigoid (BP) is a skin autoimmune blistering disease characterized by immune-mediated degradation of the dermo-epidermal junction and release of a large number of inflammatory cytokines. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory cytokine associated with inflammasome activation and known to be pivotal in several auto-immune and auto-inflammatory diseases. We sought to clarify the presence of inflammasome-dependent IL-1β and to investigate its role in BP. Skin biopsy specimens (n = 13), serum (n = 60), blister fluid (n = 26), and primary inflammatory cells from patients with BP were used to investigate inflammasome activation and function. We here highlighted a differential occurrence of a functional in situ inflammasome in patients with BP, biologically distinguished by IL-1β and NLRP3 expression. Clinically, elevated IL-1β levels were associated with the presence of erythema and urticarial plaques reflecting the inflammatory phase preceding blister formation. We further identified IL-17 and IL-23 as important molecules favoring IL-1β expression in monocyte-derived macrophages from BP patients. Finally, we demonstrated the ability of IL-1β to stimulate the release of the matrix metalloproteinase-9 in those macrophages, reinforcing the role of IL-1β in the auto-amplification loop of the inflammatory response associated to BP. However, whether this inflammasome is an epiphenomenon associated with BP disease or constitutes an amplification inflammatory step in certain patients still need to be determined. In the context of a precision medicine approach, our findings allowed us to delineate a subgroup of patients with BP that showed similarities with auto-inflammatory diseases. Subsequently, this opens up alternative therapeutic strategies targeting IL-1β pathway in the aim to control the early, pre-blistering inflammatory phase. Ultimately, this could also help in reducing the detrimental effects associated with high doses of corticosteroids treatment.
format Online
Article
Text
id pubmed-6718471
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67184712019-09-10 IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid Le Jan, Sébastien Muller, Céline Plee, Julie Durlach, Anne Bernard, Philippe Antonicelli, Frank Front Immunol Immunology Bullous Pemphigoid (BP) is a skin autoimmune blistering disease characterized by immune-mediated degradation of the dermo-epidermal junction and release of a large number of inflammatory cytokines. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory cytokine associated with inflammasome activation and known to be pivotal in several auto-immune and auto-inflammatory diseases. We sought to clarify the presence of inflammasome-dependent IL-1β and to investigate its role in BP. Skin biopsy specimens (n = 13), serum (n = 60), blister fluid (n = 26), and primary inflammatory cells from patients with BP were used to investigate inflammasome activation and function. We here highlighted a differential occurrence of a functional in situ inflammasome in patients with BP, biologically distinguished by IL-1β and NLRP3 expression. Clinically, elevated IL-1β levels were associated with the presence of erythema and urticarial plaques reflecting the inflammatory phase preceding blister formation. We further identified IL-17 and IL-23 as important molecules favoring IL-1β expression in monocyte-derived macrophages from BP patients. Finally, we demonstrated the ability of IL-1β to stimulate the release of the matrix metalloproteinase-9 in those macrophages, reinforcing the role of IL-1β in the auto-amplification loop of the inflammatory response associated to BP. However, whether this inflammasome is an epiphenomenon associated with BP disease or constitutes an amplification inflammatory step in certain patients still need to be determined. In the context of a precision medicine approach, our findings allowed us to delineate a subgroup of patients with BP that showed similarities with auto-inflammatory diseases. Subsequently, this opens up alternative therapeutic strategies targeting IL-1β pathway in the aim to control the early, pre-blistering inflammatory phase. Ultimately, this could also help in reducing the detrimental effects associated with high doses of corticosteroids treatment. Frontiers Media S.A. 2019-08-27 /pmc/articles/PMC6718471/ /pubmed/31507596 http://dx.doi.org/10.3389/fimmu.2019.01972 Text en Copyright © 2019 Le Jan, Muller, Plee, Durlach, Bernard and Antonicelli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Le Jan, Sébastien
Muller, Céline
Plee, Julie
Durlach, Anne
Bernard, Philippe
Antonicelli, Frank
IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
title IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
title_full IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
title_fullStr IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
title_full_unstemmed IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
title_short IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
title_sort il-23/il-17 axis activates il-1β-associated inflammasome in macrophages and generates an auto-inflammatory response in a subgroup of patients with bullous pemphigoid
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718471/
https://www.ncbi.nlm.nih.gov/pubmed/31507596
http://dx.doi.org/10.3389/fimmu.2019.01972
work_keys_str_mv AT lejansebastien il23il17axisactivatesil1bassociatedinflammasomeinmacrophagesandgeneratesanautoinflammatoryresponseinasubgroupofpatientswithbullouspemphigoid
AT mullerceline il23il17axisactivatesil1bassociatedinflammasomeinmacrophagesandgeneratesanautoinflammatoryresponseinasubgroupofpatientswithbullouspemphigoid
AT pleejulie il23il17axisactivatesil1bassociatedinflammasomeinmacrophagesandgeneratesanautoinflammatoryresponseinasubgroupofpatientswithbullouspemphigoid
AT durlachanne il23il17axisactivatesil1bassociatedinflammasomeinmacrophagesandgeneratesanautoinflammatoryresponseinasubgroupofpatientswithbullouspemphigoid
AT bernardphilippe il23il17axisactivatesil1bassociatedinflammasomeinmacrophagesandgeneratesanautoinflammatoryresponseinasubgroupofpatientswithbullouspemphigoid
AT antonicellifrank il23il17axisactivatesil1bassociatedinflammasomeinmacrophagesandgeneratesanautoinflammatoryresponseinasubgroupofpatientswithbullouspemphigoid